| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00217464 Details | 2015-04-16 Interventional | 2 | 17 | Fulvestrant Prostatic Neopl… Prostate Cancer | Closed for futility - | |||
| NCT00003880 Details | 2015-04-16 Interventional | 2/3 | 132 | Carboplatin Paclitaxel Ovarian Cancer Primary Periton… | - - | |||
| NCT01851408 Details | 2015-04-15 Interventional | 2 | 0 | MTOR Inhibitors Sirolimus Sorafenib Temsirolimus Melanoma Recurrence Recurrent Melan… Stage III Melan… Stage IV Melano… | No progression of Phase 1 trial to Phase 2. - | |||
| NCT01235741 Details | 2015-04-15 Interventional | 2 | 213 | Pramlintide Obesity | Results from previous study DFA102 demonstrated neutralizing activity to metreleptin in invitro
assay in 2 participants. - | |||
| NCT01193491 Details | 2015-04-15 Interventional | 1 | 4 | Geldanamycin Hematologic Neo… Neoplasms Hematologic Mal… | Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus on Retaspimycin
HCL - | |||
| NCT01071564 Details | 2015-04-15 Interventional | 1 | 13 | 2,2-dimethyl-N-… Gamma Secretase… Breast Neoplasm… Carcinoma Estrogen Recept… HER2/Neu Negati… Progesterone Re… Recurrent Breas… Stage IIIB Brea… Stage IIIC Brea… Stage IV Breast… Triple-Negative… | - - | |||
| NCT00716469 Details | 2015-04-15 Interventional | 1 | 7 | Talaporfin Neurofibroma Neurofibroma, P… Neurofibromatos… | The study is terminated due to expiration of study materials. - | |||
| NCT00022542 Details | 2015-04-15 Interventional | 2 | 26 | Epothilone B Epothilones Sarcoma Recurrent Adult… Stage III Adult… Stage IV Adult … | - - | |||
| NCT01334892 2008-003800-73 Details | 2015-04-14 Interventional | 2/3 | 130 | Cyclosporine Cyclosporins Bronchiolitis Bronchiolitis O… Bronchiolitis O… | Interim analysis results revealed substantial increase of patient number, with unfeasible study
prolongation. - | |||
| NCT00943553 Details | 2015-04-13 Interventional | 2 | 0 | Decitabine Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myelogeno… | Terminated by Sponsor - | |||
| NCT00081900 Details | 2015-04-13 Interventional | 1/2 | 38 | N(1),N(11)-diet… Carcinoma Carcinoma, Hepa… | This study was terminated early by Genzyme because there were insufficient data to support
clinical benefit to HCC patients on the study. - | |||
| NCT00157508 Details | 2015-04-09 Interventional | 2 | - | Nitroaspirin Diabetes Mellit… Diabetes Mellit… Kidney Diseases Early Nephropat… Type 2 Diabetes | - - | |||
| NCT01714037 Details | 2015-04-08 Interventional | 1 | 82 | Docetaxel Gemcitabine Pemetrexed Carcinoma, Non-… Lung Neoplasms Non-small Cell … | - - | |||
| NCT01113229 2009-013177-18 Details | 2015-04-08 Interventional | 4 | 1721 | Misoprostol Hemorrhage Postpartum Hemo… Hemorrhage; Com… | reason of halt prematurely: futility of the trial - | |||
| NCT00885924 Details | 2015-04-08 Interventional | 4 | 17 | Deamino Arginin… Hemorrhage Postoperative H… Postoperative B… | to include required number of patients took too much time - | |||
| NCT00586976 Details | 2015-04-07 Interventional | 2/3 | 125 | Ropivacaine Cardiac Surgery | Stopped by DSMB due to increased wound infection rate. - | |||
| NCT00368719 Details | 2015-04-07 Interventional | 4 | 0 | Tacrolimus Dermatitis Dermatitis, Ato… Eczema Atopic Dermatit… | withdrawn due to contractual issues - | |||
| NCT00169091 Details | 2015-04-07 Interventional | 4 | 32 | Clozapine Haloperidol Haloperidol dec… Schizophrenia | - - | |||
| NCT00169039 Details | 2015-04-07 Interventional | 4 | - | Chlorpromazine Clozapine Schizophrenia | - - | |||
| NCT01878864 2012-003430-16 Details | 2015-04-03 Interventional | 2 | 12 | Bupivacaine Lidocaine Periodontitis Pain and Discom… | Too slow patient inclusion and superior effect of the injection - |